Zkusit zdarma
KalVista Pharmaceuticals, Inc.

KalVista Pharmaceuticals, Inc.

KALV
Cena:
$ 26.79
+0.02 (0.07%)
Valuace
70
Růst
15
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
KalVista Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of KalVista Pharmaceuticals, Inc. - KALV

KalVista Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of KalVista Pharmaceuticals, Inc. - KALV

15:00 19-05-2026

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of [url="]Kahn Swic...

KalVista Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of KalVista Pharmaceuticals, Inc. - KALV

KalVista Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of KalVista Pharmaceuticals, Inc. - KALV

14:11 19-05-2026

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., ...

KalVista Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of KalVista Pharmaceuticals, Inc. - KALV

KalVista Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of KalVista Pharmaceuticals, Inc. - KALV

12:30 01-05-2026

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, ...

Stock Market Today, April 29: KalVista Pharmaceuticals Surges on Chiesi Group Acquisition Announcement

Stock Market Today, April 29: KalVista Pharmaceuticals Surges on Chiesi Group Acquisition Announcement

17:47 29-04-2026

On April 29, 2026, a rare-disease deal reshapes biotech M&A expectations as investors weigh tender t...

Shareholder Alert: Ademi LLP investigates whether KalVista Pharmaceuticals Inc. is obtaining a Fair Price for Public Shareholders

Shareholder Alert: Ademi LLP investigates whether KalVista Pharmaceuticals Inc. is obtaining a Fair Price for Public Shareholders

12:17 29-04-2026

MILWAUKEE, April 29, 2026 /PRNewswire/ -- Ademi LLP is investigating KalVista (NASDAQ: KALV) for pos...

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of KalVista Pharmaceuticals, Inc. (NASDAQ: KALV)

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of KalVista Pharmaceuticals, Inc. (NASDAQ: KALV)

11:01 29-04-2026

NEW YORK, April 29, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde a...

KALV Stock Alert: Halper Sadeh LLC is Investigating Whether KalVista Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders

KALV Stock Alert: Halper Sadeh LLC is Investigating Whether KalVista Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders

10:17 29-04-2026

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale ...

Italian drugmaker Chiesi to buy KalVista for $1.9 billion

Italian drugmaker Chiesi to buy KalVista for $1.9 billion

7:53 29-04-2026

Italy's ​Chiesi has ‌agreed to ​buy ​KalVista Pharmaceuticals ⁠for ​about $1.9 billion, ...

Italian pharma group Chiesi to buy US peer KalVista for $1.9 billion

Italian pharma group Chiesi to buy US peer KalVista for $1.9 billion

7:11 29-04-2026

Italian pharma company Chiesi Group will buy U.S.-listed KalVista Pharmaceuticals in an all-cash dea...

KalVista Pharmaceuticals (NASDAQ:KALV) Insider Paul Audhya Sells 2,686 Shares of Stock

KalVista Pharmaceuticals (NASDAQ:KALV) Insider Paul Audhya Sells 2,686 Shares of Stock

5:26 21-04-2026

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV - Get Free Report) insider Paul Audhya sold 2,686 share...

KalVista Pharmaceuticals (NASDAQ:KALV) Insider Nicole Sweeny Sells 1,862 Shares

KalVista Pharmaceuticals (NASDAQ:KALV) Insider Nicole Sweeny Sells 1,862 Shares

5:26 21-04-2026

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV - Get Free Report) insider Nicole Sweeny sold 1,862 sha...

KalVista Pharmaceuticals (NASDAQ:KALV) CFO Brian Piekos Sells 1,862 Shares of Stock

KalVista Pharmaceuticals (NASDAQ:KALV) CFO Brian Piekos Sells 1,862 Shares of Stock

5:26 21-04-2026

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV - Get Free Report) CFO Brian Piekos sold 1,862 shares o...

KalVista Pharmaceuticals Touts EKTERLY Launch: Nearly $50M in Under 6 Months, 20% Patient Reach

KalVista Pharmaceuticals Touts EKTERLY Launch: Nearly $50M in Under 6 Months, 20% Patient Reach

1:05 18-04-2026

KalVista Pharmaceuticals (NASDAQ: KALV) CEO Ben Palleiko told investors at Needham and Company's 25t...

KalVista Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference

KalVista Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference

7:00 08-04-2026

FRAMINGHAM, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (Nasdaq: KAL...

KalVista Pharmaceuticals: Ekterly's Launch Momentum Keeps The Bull Case Alive

KalVista Pharmaceuticals: Ekterly's Launch Momentum Keeps The Bull Case Alive

6:11 07-04-2026

KalVista Pharmaceuticals is now a commercial rare-disease play with Ekterly established as the first...

KalVista Pharmaceuticals (NASDAQ:KALV) Trading 8.7% Higher Following Analyst Upgrade

KalVista Pharmaceuticals (NASDAQ:KALV) Trading 8.7% Higher Following Analyst Upgrade

2:46 27-03-2026

Shares of KalVista Pharmaceuticals, Inc. (NASDAQ: KALV - Get Free Report) shot up 8.7% on Thursday a...

KalVista Pharmaceuticals (NASDAQ:KALV) Sets New 12-Month High Following Analyst Upgrade

KalVista Pharmaceuticals (NASDAQ:KALV) Sets New 12-Month High Following Analyst Upgrade

2:46 27-03-2026

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV - Get Free Report)'s stock price reached a new 52-week ...

KalVista Pharmaceuticals, Inc. (KALV) 8 Months 2025 Earnings Call Transcript

KalVista Pharmaceuticals, Inc. (KALV) 8 Months 2025 Earnings Call Transcript

14:55 25-03-2026

KalVista Pharmaceuticals, Inc. (KALV) 8 Months 2025 Earnings Call Transcript...

KalVista Pharmaceuticals Reports Eight Months Fiscal Year 2025 Financial Results and Provides Corporate Update

KalVista Pharmaceuticals Reports Eight Months Fiscal Year 2025 Financial Results and Provides Corporate Update

7:00 25-03-2026

FRAMINGHAM, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (Nasdaq: KAL...

Wall Street Analysts Think KalVista Pharmaceuticals (KALV) Could Surge 117.1%: Read This Before Placing a Bet

Wall Street Analysts Think KalVista Pharmaceuticals (KALV) Could Surge 117.1%: Read This Before Placing a Bet

10:55 24-02-2026

The consensus price target hints at an 117.1% upside potential for KalVista Pharmaceuticals (KALV). ...

close

KALVISTA PHARMACEUTICALS TO PRESENT EKTERLY® (SEBETRALSTAT) DATA AT THE 2026 AMERICAN ACADEMY OF ALLERGY, ASTHMA & IMMUNOLOGY ANNUAL MEETING

12-02-2026
FRAMINGHAM, MASS. & SALISBURY, ENGLAND--(BUSINESS WIRE)--KALVISTA PHARMACEUTICALS, INC. (NASDAQ: KAL...
Více zde

KALVISTA PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

03-02-2026
FRAMINGHAM, MASS. & SALISBURY, ENGLAND--(BUSINESS WIRE)--KALVISTA PHARMACEUTICALS, INC. (NASDAQ: KAL...
Více zde

KALVISTA PHARMACEUTICALS PROVIDES UPDATE ON STRONG EKTERLY® LAUNCH WITH PRELIMINARY FOURTH QUARTER AND FULL YEAR 2025 REVENUE RESULTS

08-01-2026
FRAMINGHAM, MASS. & SALISBURY, ENGLAND--(BUSINESS WIRE)--KALVISTA PHARMACEUTICALS, INC. (NASDAQ: KAL...
Více zde

KALVISTA PHARMACEUTICALS ANNOUNCES APPROVAL OF EKTERLY® (SEBETRALSTAT) IN JAPAN, FIRST AND ONLY ORAL ON-DEMAND TREATMENT FOR HEREDITARY ANGIOEDEMA

22-12-2025
FRAMINGHAM, MASS. & SALISBURY, ENGLAND--(BUSINESS WIRE)--KALVISTA PHARMACEUTICALS, INC. (NASDAQ: KAL...
Více zde

KALVISTA PHARMACEUTICALS PROVIDES OPERATIONAL UPDATE AND REPORTS THIRD QUARTER FINANCIAL RESULTS

10-11-2025
FRAMINGHAM, MASS. & SALISBURY, ENGLAND--(BUSINESS WIRE)--KALVISTA PHARMACEUTICALS, INC. (NASDAQ: KAL...
Více zde

KALVISTA PHARMACEUTICALS PRESENTS NEW DATA HIGHLIGHTING PATIENT SATISFACTION WITH EKTERLY® (SEBETRALSTAT) AND ITS POTENTIAL IN CHILDREN AGES 2-11 AT THE ACAAI 2025 ANNUAL SCIENTIFIC MEETING

06-11-2025
FRAMINGHAM, MASS. & SALISBURY, ENGLAND--(BUSINESS WIRE)--KALVISTA PHARMACEUTICALS, INC. (NASDAQ: KAL...
Více zde

KALVISTA PHARMACEUTICALS TO PRESENT AT UPCOMING INVESTOR CONFERENCES

05-11-2025
FRAMINGHAM, MASS. & SALISBURY, ENGLAND--(BUSINESS WIRE)--KALVISTA PHARMACEUTICALS, INC. (NASDAQ: KAL...
Více zde

KALVISTA PHARMACEUTICALS TO HOST THIRD QUARTER FINANCIAL RESULTS CONFERENCE CALL AND WEBCAST ON NOVEMBER 11, 2025

03-11-2025
FRAMINGHAM, MASS. & SALISBURY, ENGLAND--(BUSINESS WIRE)--KALVISTA PHARMACEUTICALS, INC. (NASDAQ: KAL...
Více zde

KALVISTA PHARMACEUTICALS PRESENTS NEW DATA HIGHLIGHTING THE POTENTIAL OF EKTERLY® (SEBETRALSTAT) TO TRANSFORM ON-DEMAND HEREDITARY ANGIOEDEMA TREATMENT IN EUROPE

06-10-2025
FRAMINGHAM, MASS. & SALISBURY, ENGLAND--(BUSINESS WIRE)--KALVISTA PHARMACEUTICALS, INC. (NASDAQ: KAL...
Více zde

KALVISTA PHARMACEUTICALS APPOINTS BILAL ARIF AS CHIEF OPERATING OFFICER AND LINEA ASPESI AS CHIEF PEOPLE OFFICER

06-10-2025
FRAMINGHAM, MASS. & SALISBURY, ENGLAND--(BUSINESS WIRE)--KALVISTA PHARMACEUTICALS, INC. (NASDAQ: KAL...
Více zde

KALVISTA PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

03-10-2025
FRAMINGHAM, MASS. & SALISBURY, ENGLAND--(BUSINESS WIRE)--KALVISTA PHARMACEUTICALS, INC. (NASDAQ: KAL...
Více zde

KALVISTA PHARMACEUTICALS ANNOUNCES APPOINTMENT OF BETHANY L. SENSENIG TO BOARD OF DIRECTORS

02-10-2025
FRAMINGHAM, MASS. & SALISBURY, ENGLAND--(BUSINESS WIRE)--KALVISTA PHARMACEUTICALS, INC. (NASDAQ: KAL...
Více zde

KALVISTA PHARMACEUTICALS TO PRESENT NEW EKTERLY® (SEBETRALSTAT) DATA AT THE 20TH GERMAN ALLERGY CONGRESS

26-09-2025
FRAMINGHAM, MASS. & SALISBURY, ENGLAND--(BUSINESS WIRE)--KALVISTA PHARMACEUTICALS, INC. (NASDAQ: KAL...
Více zde

KALVISTA PRICES UPSIZED OFFERING OF $125.0 MILLION OF 3.250% CONVERTIBLE SENIOR NOTES DUE 2031

24-09-2025
FRAMINGHAM, MASS. & SALISBURY, ENGLAND--(BUSINESS WIRE)--KALVISTA PHARMACEUTICALS, INC. (“KALVISTA...
Více zde

KALVISTA PHARMACEUTICALS ANNOUNCES PROPOSED OFFERING OF $110.0 MILLION OF CONVERTIBLE SENIOR NOTES

24-09-2025
FRAMINGHAM, MASS. & SALISBURY, ENGLAND--(BUSINESS WIRE)--KALVISTA PHARMACEUTICALS, INC. (“KALVISTA...
Více zde

KALVISTA PHARMACEUTICALS ANNOUNCES EUROPEAN COMMISSION AND SWISSMEDIC APPROVAL OF EKTERLY® (SEBETRALSTAT), FIRST AND ONLY ORAL ON-DEMAND TREATMENT FOR HEREDITARY ANGIOEDEMA

19-09-2025
FRAMINGHAM, MASS. & SALISBURY, ENGLAND--(BUSINESS WIRE)--KALVISTA PHARMACEUTICALS, INC. (NASDAQ: KAL...
Více zde

KALVISTA PHARMACEUTICALS PROVIDES OPERATIONAL UPDATE AND REPORTS FISCAL QUARTER FINANCIAL RESULTS

11-09-2025
FRAMINGHAM, MASS. & SALISBURY, ENGLAND--(BUSINESS WIRE)--KALVISTA PHARMACEUTICALS, INC. (NASDAQ: KAL...
Více zde

KALVISTA PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

04-09-2025
CAMBRIDGE, MASS. & SALISBURY, ENGLAND--(BUSINESS WIRE)--KALVISTA PHARMACEUTICALS, INC. (NASDAQ: KALV...
Více zde

METAGENOMI APPOINTS LAURENCE REID, PHD TO ITS BOARD OF DIRECTORS

11-08-2025
EMERYVILLE, CALIF., AUG. 11, 2025 (GLOBE NEWSWIRE) -- METAGENOMI, INC. (NASDAQ: MGX) (THE “COMPANY...
Více zde

KALVISTA PHARMACEUTICALS ANNOUNCES MAINTENANCE OF ORPHAN DESIGNATION FOR SEBETRALSTAT IN EUROPEAN UNION

11-08-2025
CAMBRIDGE, MASS. & SALISBURY, ENGLAND--(BUSINESS WIRE)--KALVISTA PHARMACEUTICALS, INC. (NASDAQ: KALV...
Více zde

KALVISTA PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

04-08-2025
CAMBRIDGE, MASS. & SALISBURY, ENGLAND--(BUSINESS WIRE)--KALVISTA PHARMACEUTICALS, INC. (NASDAQ: KALV...
Více zde

KALVISTA PHARMACEUTICALS RECEIVES POSITIVE CHMP OPINION FOR SEBETRALSTAT FOR THE TREATMENT OF HEREDITARY ANGIOEDEMA ATTACKS

25-07-2025
CAMBRIDGE, MASS. & SALISBURY, ENGLAND--(BUSINESS WIRE)--KALVISTA PHARMACEUTICALS, INC. (NASDAQ: KALV...
Více zde

KALVISTA PHARMACEUTICALS ANNOUNCES UK MHRA APPROVAL OF EKTERLY® (SEBETRALSTAT), FIRST AND ONLY ORAL ON-DEMAND TREATMENT FOR HEREDITARY ANGIOEDEMA

15-07-2025
CAMBRIDGE, MASS. & SALISBURY, ENGLAND--(BUSINESS WIRE)--KALVISTA PHARMACEUTICALS, INC. (NASDAQ: KALV...
Více zde

KALVISTA PHARMACEUTICALS PROVIDES OPERATIONAL UPDATE AND FISCAL YEAR 2025 FINANCIAL RESULTS

10-07-2025
CAMBRIDGE, MASS. & SALISBURY, ENGLAND--(BUSINESS WIRE)--KALVISTA PHARMACEUTICALS, INC. (NASDAQ: KALV...
Více zde

KALVISTA PHARMACEUTICALS ANNOUNCES FDA APPROVAL OF EKTERLY® (SEBETRALSTAT), FIRST AND ONLY ORAL ON-DEMAND TREATMENT FOR HEREDITARY ANGIOEDEMA

07-07-2025
CAMBRIDGE, MASS. & SALISBURY, ENGLAND--(BUSINESS WIRE)--KALVISTA PHARMACEUTICALS, INC. (NASDAQ: KALV...
Více zde

KALVISTA PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

02-07-2025
CAMBRIDGE, MASS. & SALISBURY, ENGLAND--(BUSINESS WIRE)--KALVISTA PHARMACEUTICALS, INC. (NASDAQ: KALV...
Více zde

KALVISTA PHARMACEUTICALS ENTERS INTO LICENSING AGREEMENT WITH PENDOPHARM TO COMMERCIALIZE SEBETRALSTAT FOR HAE IN CANADA

26-06-2025
CAMBRIDGE, MASS. & SALISBURY, ENGLAND--(BUSINESS WIRE)--KALVISTA PHARMACEUTICALS, INC. (NASDAQ: KALV...
Více zde

KALVISTA PHARMACEUTICALS PRESENTS NEW DATA AT THE EUROPEAN ACADEMY OF ALLERGY AND CLINICAL IMMUNOLOGY CONGRESS 2025 ON THE EFFICACY OF SEBETRALSTAT FOR THE ON-DEMAND TREATMENT OF HAE ATTACKS AMONG PATIENTS RECEIVING LONG-TERM PROPHYLAXIS

16-06-2025
CAMBRIDGE, MASS. & SALISBURY, ENGLAND--(BUSINESS WIRE)--KALVISTA PHARMACEUTICALS, INC. (NASDAQ: KALV...
Více zde

KALVISTA PHARMACEUTICALS ANNOUNCES FDA WILL NOT MEET PDUFA GOAL DATE FOR SEBETRALSTAT NDA FOR HEREDITARY ANGIOEDEMA DUE TO FDA RESOURCE CONSTRAINTS

13-06-2025
CAMBRIDGE, MASS. & SALISBURY, ENGLAND--(BUSINESS WIRE)--KALVISTA PHARMACEUTICALS, INC. (NASDAQ: KALV...
Více zde

KALVISTA PHARMACEUTICALS TO PRESENT NEW SEBETRALSTAT DATA AT THE EUROPEAN ACADEMY OF ALLERGY AND CLINICAL IMMUNOLOGY CONGRESS 2025

05-06-2025
CAMBRIDGE, MASS. & SALISBURY, ENGLAND--(BUSINESS WIRE)--KALVISTA PHARMACEUTICALS, INC. (NASDAQ: KALV...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-01-08 00:00:008-KStáhnout
2025-11-10 00:00:008-KStáhnout
2025-11-10 00:00:0010-QStáhnout
2025-10-06 01:00:008-KStáhnout
2025-10-06 00:00:008-KStáhnout
2025-10-02 01:00:008-KStáhnout
2025-10-02 00:00:008-KStáhnout
2025-09-29 01:00:008-KStáhnout
2025-09-29 00:00:008-KStáhnout
2025-09-11 01:00:008-KStáhnout
2025-09-11 01:00:0010-QStáhnout
2025-09-11 00:00:008-KStáhnout
2025-09-11 00:00:0010-QStáhnout
2025-08-21 01:00:008-KStáhnout
2025-08-21 00:00:008-KStáhnout
2025-07-10 01:00:008-KStáhnout
2025-07-10 01:00:0010-KStáhnout
2025-07-10 00:00:008-KStáhnout
2025-07-10 00:00:0010-KStáhnout
2025-07-07 01:00:008-KStáhnout
2025-07-07 00:00:008-KStáhnout
2025-05-12 01:00:008-KStáhnout
2025-05-12 00:00:008-KStáhnout
2025-04-08 01:00:008-KStáhnout
2025-04-08 00:00:008-KStáhnout
2025-03-17 00:00:008-KStáhnout
2025-03-16 23:00:008-KStáhnout
2025-03-12 00:00:008-KStáhnout
2025-03-12 00:00:0010-QStáhnout
2025-03-11 23:00:008-KStáhnout
2025-03-11 23:00:0010-QStáhnout
2024-12-16 00:00:008-KStáhnout
2024-12-15 23:00:008-KStáhnout
2024-12-05 00:00:008-KStáhnout
2024-12-05 00:00:0010-QStáhnout
2024-12-04 23:00:008-KStáhnout
2024-12-04 23:00:0010-QStáhnout
2024-11-26 00:00:008-KStáhnout
2024-11-25 23:00:008-KStáhnout
2024-11-04 00:00:008-KStáhnout
2024-11-03 23:00:008-KStáhnout
2024-10-04 01:00:008-KStáhnout
2024-10-04 00:00:008-KStáhnout
2024-09-10 01:00:008-KStáhnout
2024-09-10 00:00:008-KStáhnout
2024-09-05 01:00:008-KStáhnout
2024-09-05 01:00:0010-QStáhnout
2024-09-05 00:00:008-KStáhnout
2024-09-05 00:00:0010-QStáhnout
2024-07-23 01:00:008-KStáhnout
2024-07-23 00:00:008-KStáhnout
2024-07-11 01:00:008-KStáhnout
2024-07-11 01:00:0010-KStáhnout
2024-07-11 00:00:008-KStáhnout
2024-07-11 00:00:0010-KStáhnout
2024-04-22 01:00:008-KStáhnout
2024-04-22 00:00:008-KStáhnout
2024-03-11 00:00:008-KStáhnout
2024-03-11 00:00:0010-QStáhnout
2024-03-10 23:00:008-KStáhnout
2024-03-10 23:00:0010-QStáhnout
2024-03-07 00:00:008-KStáhnout
2024-03-06 23:00:008-KStáhnout
2024-02-16 00:00:008-KStáhnout
2024-02-15 23:00:008-KStáhnout
2024-02-14 00:00:008-KStáhnout
2024-02-13 23:00:008-KStáhnout
2024-02-13 00:00:008-KStáhnout
2024-02-12 23:00:008-KStáhnout
2023-12-07 00:00:008-KStáhnout
2023-12-07 00:00:0010-QStáhnout
2023-12-06 23:00:008-KStáhnout
2023-12-06 23:00:0010-QStáhnout
2023-09-28 01:00:008-KStáhnout
2023-09-28 00:00:008-KStáhnout
2023-09-07 01:00:008-KStáhnout
2023-09-07 01:00:0010-QStáhnout
2023-09-07 00:00:008-KStáhnout
2023-09-07 00:00:0010-QStáhnout
2023-07-10 01:00:008-KStáhnout
2023-07-10 01:00:0010-KStáhnout
2023-07-10 00:00:008-KStáhnout
2023-07-10 00:00:0010-KStáhnout
2023-06-14 01:00:008-KStáhnout
2023-06-14 00:00:008-KStáhnout
2023-03-09 00:00:008-KStáhnout
2023-03-09 00:00:0010-QStáhnout
2023-03-08 23:00:008-KStáhnout
2023-03-08 23:00:0010-QStáhnout
2023-01-05 00:00:008-KStáhnout
2023-01-04 23:00:008-KStáhnout
2022-12-27 00:00:008-KStáhnout
2022-12-26 23:00:008-KStáhnout
2022-12-08 00:00:008-KStáhnout
2022-12-08 00:00:0010-QStáhnout
2022-12-07 23:00:008-KStáhnout
2022-12-07 23:00:0010-QStáhnout
2022-10-17 01:00:008-KStáhnout
2022-10-17 00:00:008-KStáhnout
2022-09-08 01:00:008-KStáhnout
2022-09-08 01:00:0010-QStáhnout
2022-09-08 00:00:008-KStáhnout
2022-09-08 00:00:0010-QStáhnout
2022-07-07 01:00:008-KStáhnout
2022-07-07 01:00:0010-KStáhnout
2022-07-07 00:00:008-KStáhnout
2022-07-07 00:00:0010-KStáhnout
2022-05-27 01:00:008-KStáhnout
2022-05-27 00:00:008-KStáhnout
2022-03-10 00:00:008-KStáhnout
2022-03-10 00:00:0010-QStáhnout
2022-03-09 23:00:008-KStáhnout
2022-03-09 23:00:0010-QStáhnout
2022-03-07 00:00:008-KStáhnout
2022-03-06 23:00:008-KStáhnout
2021-12-09 00:00:008-KStáhnout
2021-12-09 00:00:0010-QStáhnout
2021-12-08 23:00:008-KStáhnout
2021-12-08 23:00:0010-QStáhnout
2021-10-04 01:00:008-KStáhnout
2021-10-04 00:00:008-KStáhnout
2021-09-15 01:00:008-KStáhnout
2021-09-15 00:00:008-KStáhnout
2021-09-09 01:00:008-KStáhnout
2021-09-09 01:00:0010-QStáhnout
2021-09-09 00:00:008-KStáhnout
2021-09-09 00:00:0010-QStáhnout
2021-07-13 01:00:008-KStáhnout
2021-07-13 01:00:0010-KStáhnout
2021-07-13 00:00:008-KStáhnout
2021-07-13 00:00:0010-KStáhnout
2021-06-30 01:00:008-KStáhnout
2021-06-30 00:00:008-KStáhnout
2021-06-07 01:00:008-KStáhnout
2021-06-07 00:00:008-KStáhnout
2021-03-19 00:00:008-KStáhnout
2021-03-18 23:00:008-KStáhnout
2021-03-11 00:00:008-KStáhnout
2021-03-11 00:00:0010-QStáhnout
2021-03-10 23:00:008-KStáhnout
2021-03-10 23:00:0010-QStáhnout
2021-02-11 00:00:008-KStáhnout
2021-02-10 23:00:008-KStáhnout
2021-01-27 00:00:008-KStáhnout
2021-01-26 23:00:008-KStáhnout
2020-12-18 00:00:008-KStáhnout
2020-12-17 23:00:008-KStáhnout
2020-12-10 00:00:008-KStáhnout
2020-12-10 00:00:0010-QStáhnout
2020-12-09 23:00:008-KStáhnout
2020-12-09 23:00:0010-QStáhnout
2020-12-01 00:00:008-KStáhnout
2020-11-30 23:00:008-KStáhnout
2020-11-16 00:00:008-KStáhnout
2020-11-15 23:00:008-KStáhnout
2020-10-02 01:00:008-KStáhnout
2020-10-02 00:00:008-KStáhnout
2020-09-14 01:00:008-KStáhnout
2020-09-14 01:00:0010-QStáhnout
2020-09-14 00:00:008-KStáhnout
2020-09-14 00:00:0010-QStáhnout
2020-07-01 01:00:008-KStáhnout
2020-07-01 01:00:0010-KStáhnout
2020-07-01 00:00:008-KStáhnout
2020-07-01 00:00:0010-KStáhnout
2020-06-11 01:00:008-KStáhnout
2020-06-11 00:00:008-KStáhnout
2020-03-10 00:00:008-KStáhnout
2020-03-10 00:00:0010-QStáhnout
2020-03-09 23:00:008-KStáhnout
2020-03-09 23:00:0010-QStáhnout
2019-12-03 00:00:008-KStáhnout
2019-12-03 00:00:0010-QStáhnout
2019-12-02 23:00:008-KStáhnout
2019-12-02 23:00:0010-QStáhnout
2019-10-03 01:00:008-KStáhnout
2019-10-03 00:00:008-KStáhnout
2019-09-09 01:00:008-KStáhnout
2019-09-09 01:00:0010-QStáhnout
2019-09-09 00:00:008-KStáhnout
2019-09-09 00:00:0010-QStáhnout
2019-07-16 01:00:008-KStáhnout
2019-07-16 01:00:0010-KStáhnout
2019-07-16 00:00:008-KStáhnout
2019-07-16 00:00:0010-KStáhnout
2019-07-01 01:00:008-KStáhnout
2019-07-01 00:00:008-KStáhnout
2019-04-24 01:00:008-KStáhnout
2019-04-24 00:00:008-KStáhnout
2019-03-29 00:00:008-KStáhnout
2019-03-28 23:00:008-KStáhnout
2019-03-14 00:00:008-KStáhnout
2019-03-14 00:00:0010-QStáhnout
2019-03-13 23:00:008-KStáhnout
2019-03-13 23:00:0010-QStáhnout
2019-02-01 00:00:008-KStáhnout
2019-01-31 23:00:008-KStáhnout
2018-12-14 00:00:008-KStáhnout
2018-12-14 00:00:0010-QStáhnout
2018-12-13 23:00:008-KStáhnout
2018-12-13 23:00:0010-QStáhnout
2018-10-04 01:00:008-KStáhnout
2018-10-04 00:00:008-KStáhnout
2018-09-26 01:00:008-KStáhnout
2018-09-26 00:00:008-KStáhnout
2018-09-14 01:00:0010-QStáhnout
2018-09-14 00:00:0010-QStáhnout
2018-09-06 01:00:008-KStáhnout
2018-09-06 00:00:008-KStáhnout
2018-08-01 01:00:008-KStáhnout
2018-08-01 00:00:008-KStáhnout
2018-07-31 01:00:008-KStáhnout
2018-07-31 00:00:008-KStáhnout
2018-07-30 01:00:0010-KStáhnout
2018-07-30 00:00:0010-KStáhnout
2018-06-29 01:00:008-KStáhnout
2018-06-29 00:00:008-KStáhnout
2018-05-02 01:00:008-KStáhnout
2018-05-02 00:00:008-KStáhnout
2018-04-20 01:00:008-KStáhnout
2018-04-20 00:00:008-KStáhnout
2018-03-16 00:00:008-KStáhnout
2018-03-16 00:00:0010-QStáhnout
2018-03-15 23:00:008-KStáhnout
2018-03-15 23:00:0010-QStáhnout
2017-12-14 00:00:008-KStáhnout
2017-12-14 00:00:0010-QStáhnout
2017-12-13 23:00:008-KStáhnout
2017-12-13 23:00:0010-QStáhnout
2017-10-10 01:00:008-KStáhnout
2017-10-10 00:00:008-KStáhnout
2017-09-28 01:00:008-KStáhnout
2017-09-28 00:00:008-KStáhnout
2017-09-14 01:00:008-KStáhnout
2017-09-14 01:00:0010-QStáhnout
2017-09-14 00:00:008-KStáhnout
2017-09-14 00:00:0010-QStáhnout
2017-08-25 01:00:008-KStáhnout
2017-08-25 00:00:008-KStáhnout
2017-07-27 01:00:008-KStáhnout
2017-07-27 01:00:0010-KStáhnout
2017-07-27 00:00:008-KStáhnout
2017-07-27 00:00:0010-KStáhnout
2017-07-13 01:00:008-KStáhnout
2017-07-13 00:00:008-KStáhnout
2017-05-30 01:00:008-KStáhnout
2017-05-30 00:00:008-KStáhnout
2017-03-27 01:00:008-KStáhnout
2017-03-27 00:00:008-KStáhnout
2017-03-17 00:00:008-KStáhnout
2017-03-16 23:00:008-KStáhnout
2017-03-16 00:00:0010-QStáhnout
2017-03-15 23:00:0010-QStáhnout
2016-11-23 00:00:008-KStáhnout
2016-11-22 23:00:008-KStáhnout
2016-11-21 00:00:008-KStáhnout
2016-11-20 23:00:008-KStáhnout
2016-11-08 00:00:0010-QStáhnout
2016-11-07 23:00:0010-QStáhnout
2016-11-04 00:00:008-KStáhnout
2016-11-03 23:00:008-KStáhnout
2016-09-30 01:00:008-KStáhnout
2016-09-30 00:00:008-KStáhnout
2016-08-12 01:00:0010-QStáhnout
2016-08-12 00:00:0010-QStáhnout
2016-07-29 01:00:008-KStáhnout
2016-07-29 00:00:008-KStáhnout
2016-06-28 01:00:008-KStáhnout
2016-06-28 00:00:008-KStáhnout
2016-06-24 01:00:008-KStáhnout
2016-06-24 00:00:008-KStáhnout
2016-06-22 01:00:008-KStáhnout
2016-06-22 00:00:008-KStáhnout
2016-06-17 01:00:008-KStáhnout
2016-06-17 00:00:008-KStáhnout
2016-06-15 01:00:008-KStáhnout
2016-06-15 00:00:008-KStáhnout
2016-05-12 01:00:0010-QStáhnout
2016-05-12 00:00:0010-QStáhnout
2016-04-18 01:00:008-KStáhnout
2016-04-18 00:00:008-KStáhnout
2016-03-30 01:00:0010-KStáhnout
2016-03-30 00:00:0010-KStáhnout
2016-03-18 00:00:008-KStáhnout
2016-03-17 23:00:008-KStáhnout
2016-02-01 00:00:008-KStáhnout
2016-01-31 23:00:008-KStáhnout
2015-12-28 00:00:008-KStáhnout
2015-12-27 23:00:008-KStáhnout
2015-11-12 00:00:008-KStáhnout
2015-11-12 00:00:0010-QStáhnout
2015-11-11 23:00:008-KStáhnout
2015-11-11 23:00:0010-QStáhnout
2015-10-08 01:00:008-KStáhnout
2015-10-08 00:00:008-KStáhnout
2015-08-13 01:00:0010-QStáhnout
2015-08-13 00:00:0010-QStáhnout
2015-08-12 01:00:008-KStáhnout
2015-08-12 00:00:008-KStáhnout
2015-08-05 01:00:008-KStáhnout
2015-08-05 00:00:008-KStáhnout
2015-07-14 01:00:008-KStáhnout
2015-07-14 00:00:008-KStáhnout
2015-05-28 01:00:008-KStáhnout
2015-05-28 00:00:008-KStáhnout
2015-05-21 01:00:008-KStáhnout
2015-05-21 01:00:0010-QStáhnout
2015-05-21 00:00:008-KStáhnout
2015-05-21 00:00:0010-QStáhnout
2015-05-18 01:00:008-KStáhnout
2015-05-18 00:00:008-KStáhnout
2015-04-16 01:00:008-KStáhnout
2015-04-16 00:00:008-KStáhnout
preloader